Should heart failure patients stay on jardiance in the hospital? new trial aims to find out
Disease control
Recruiting now
This phase 3 trial studies whether patients with acute decompensated heart failure who are already taking an SGLT2 inhibitor like empagliflozin should continue it during hospitalization. About 536 participants will either keep taking empagliflozin or switch to a placebo while in …
Phase: PHASE3 • Sponsor: Christian Schulze • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC